Viewing Study NCT06001658

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:08 AM
Ignite Modification Date: 2026-01-17 @ 11:11 AM
Study NCT ID: NCT06001658
Status: RECRUITING
Last Update Posted: 2025-12-03
First Post: 2023-08-08
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Billiary Track Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Biliary Tract cancer View
None Pembrolizumab View
None Gemcitabine View
None Cisplatin View
None Immunotherapy View
None Potentially resectable biliary tract cancer View
None Anti PD-L1 View
None PD-L1 View
None Carcinoma View